In silico drug discovery made easy
We use Big Data and Artificial Intelligence to
accelerate your novel Drug Development through:
Our very easy to use SaaS platform provides a versatile set of applications to facilitate target identification and elucidate the mechanisms of action (MoA).
From in silico Drug Design to computational prediction of ADME and pharmacokinetics.
Elucidate the Mode of Action (MoA) of specific molecules and rationalize their off-target effects.
In silico screening of libraries, hit & lead expansion and drug repurposing.
Identify and characterize binding sites using Artificial Intelligence approaches.
A new study with the participation of Mind the Byte has identified a new group of phytochemicals capable of specifically and potently suppressing the functional traits of Cancer Stem Cells (CSC). The research was led by the group of Metabolism and Cancer...
It is the second most interesting overseas market for the future for Catalan firms according to 2017 Internationalization Survey In April, eight companies from the BioRegion will participate in a business mission to Canada organized by Biocat and ACCIÓ....
Yesterday, CataloniaBio & HealthTech awarded the 2018 Biosuccess Award recognising the most important business milestones in biomedicine and health in Catalonia to Anaconda Biomed and Mind the Byte. The ceremony took place during the CataloniaBio &...